Osteosarcoma (OS) is a relatively rare tumor of bone with a worldwide incidence of 3.4
cases per million people per year. For most of the twentieth century, five-year survival rates …

Osteosarcoma is a rare tumor that requires complex multidisciplinary management. This
paper reviews the general management and standard radiotherapy guidelines for …

Abstract Purpose of Review Osteosarcoma (OSA) is the most common primary tumor of
bone, mainly affecting children and adolescents. Here we discuss recent advances in …

Osteosarcoma (OS) is the most common primary malignancy of bone and patients with
metastatic disease or recurrences continue to have very poor outcomes. Unfortunately, little …

Long-term outcome for patients with high-grade osteosarcoma has improved with the
addition of systemic chemotherapy, but subsequent progress has been less marked …

Osteosarcoma is the most common malignant bone tumor, currently treated with pre-and
postoperative chemotherapy in association with the surgical removal of the tumor. About 15 …

Over the past 30 years, treatment advances and the addition of neoadjuvant chemotherapy
have led to improved 5-year survival in patients with osteosarcoma. More recent literature …

BACKGROUND: There are conflicting data regarding age as a prognostic factor in
osteosarcoma. The authors conducted a study evaluating the impact of age on prognosis in …

Osteosarcoma, a highly malignant tumor, is characterized by widespread and recurrent
chromosomal and genetic abnormalities. In recent years, a number of elaborated …

Background Appendicular osteosarcoma is the most common malignant primary canine
bone tumor. When treated by amputation or tumor removal alone, median survival times …